temozolomide has been researched along with Carcinoma, Renal Cell in 7 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Brain metastases from renal cell carcinoma (RCC) cause significant morbidity and mortality." | 2.43 | Radiation therapy in the management of brain metastases from renal cell carcinoma. ( Amato, R; Doh, LS; Paulino, AC; Teh, BS, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hribar, KC | 1 |
| Wheeler, CJ | 1 |
| Bazarov, A | 1 |
| Varshneya, K | 1 |
| Yamada, R | 1 |
| Buckley, P | 1 |
| Patil, CG | 1 |
| Polley, MY | 1 |
| Freidlin, B | 1 |
| Korn, EL | 1 |
| Conley, BA | 1 |
| Abrams, JS | 1 |
| McShane, LM | 1 |
| Park, DK | 1 |
| Ryan, CW | 1 |
| Dolan, ME | 1 |
| Vogelzang, NJ | 1 |
| Stadler, WM | 1 |
| Sunkara, U | 1 |
| Walczak, JR | 1 |
| Summerson, L | 1 |
| Rogers, T | 1 |
| Eisenberger, M | 1 |
| Denmeade, S | 1 |
| Pili, R | 1 |
| Huff, CA | 1 |
| Sinibaldi, V | 1 |
| Carducci, MA | 1 |
| Bex, A | 1 |
| Kerst, J | 1 |
| Mallo, H | 1 |
| Van Tinteren, H | 1 |
| Horenblas, S | 1 |
| De Gast, GC | 1 |
| Doh, LS | 1 |
| Amato, R | 1 |
| Paulino, AC | 1 |
| Teh, BS | 1 |
| Sawrie, SM | 1 |
| Guthrie, BL | 1 |
| Spencer, SA | 1 |
| Nordal, RA | 1 |
| Meredith, RF | 1 |
| Markert, JM | 1 |
| Cloud, GA | 1 |
| Fiveash, JB | 1 |
1 review available for temozolomide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Radiation therapy in the management of brain metastases from renal cell carcinoma.
Topics: Brain Neoplasms; Carcinoma, Renal Cell; Dacarbazine; Humans; Kidney Neoplasms; Metalloporphyrins; Ne | 2006 |
3 trials available for temozolomide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
Topics: Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma, Renal Cell; Dacarbazine; Drug | 2002 |
A phase II trial of temozolomide and IFN-alpha in patients with advanced renal cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 2004 |
Extended continuous oral temozolomide in patients with progressive metastatic renal cell carcinoma not responding to interferon alpha 2b.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality T | 2005 |
3 other studies available for temozolomide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A Simple Three-dimensional Hydrogel Platform Enables
Topics: Aged; Animals; Carcinoma, Renal Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; | 2019 |
Statistical and practical considerations for clinical evaluation of predictive biomarkers.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Dac | 2013 |
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms | 2008 |